Literature DB >> 3857964

Familial osteosarcoma associated with 13;14 chromosomal rearrangement.

P A Gilman, N Wang, S F Fan, J Reede, A Khan, B G Leventhal.   

Abstract

Two prepubertal sisters of American Indian origin developed osteosarcoma at 8 and 12 years of age. This familial occurrence, tumor onset prior to puberty, unusual tumor location in one who also had short stature, and ethnic background all suggest an inborn predisposition to bone cancer rather than a chance occurrence. Rearrangements involving chromosomes #13 and #14 were found in both the surviving proband and mother. Comparison of the arm ratio and prometaphase G-banding patterns of the rearranged chromosomes suggests either deletion of band 14q11.2 or pericentric inversion (with breakpoints at 13q12 and 14q11.2) in the proband's rearranged chromosome, but not in her mother's. Her mother, who had no malignancy, had a typical Robertsonian translocation [t(13;14)(p11;q11)]. Three previously reported children with chromosomal abnormalities developed osteosarcoma at unusually young ages, younger even than in reported sibships with osteosarcoma. The most frequently detected cytogenetic abnormalities in sarcoma tumor cells involve chromosomes #13 and #14. In addition, some cases of bilateral retinoblastoma and familial unilateral retinoblastoma, which are known to be at increased risk for osteosarcoma, are associated with tiny deletions on chromosome #13. Thus, there may be a causal relationship between constitutional loss or rearrangement of genetic material at these breakpoints on chromosomes #13 or #14 and development of osteosarcoma in this family that is similar to that seen in patients with small constitutional chromosomal deletions who develop Wilms' tumor and retinoblastoma.

Entities:  

Mesh:

Year:  1985        PMID: 3857964     DOI: 10.1016/0165-4608(85)90022-6

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  3 in total

1.  Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1).

Authors:  Barry P Pereira; Yefang Zhou; Anurag Gupta; David T Leong; Khin Zarchi Aung; Ling Ling; Robert W H Pho; Mario Galindo; Manuel Salto-Tellez; Gary S Stein; Simon M Cool; Andre J van Wijnen; Saminathan S Nathan
Journal:  J Cell Physiol       Date:  2009-12       Impact factor: 6.384

2.  Osteosarcoma in One of Identical Twins: Three Cases Report and a Literature Review.

Authors:  Jie Zhao; Wei Wang; Zhiyong Liu; Xiao Li; Qiqing Cai; Xiuchun Yu
Journal:  Orthop Surg       Date:  2021-05-05       Impact factor: 2.071

3.  Inactivation of p53 gene in human and murine osteosarcoma cells.

Authors:  N Chandar; B Billig; J McMaster; J Novak
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.